2m 2m 2m 2m 2m 2m 2m
Ocular Therapeut (OCUL)
NASDAQ
$9.88+$0.004 (+0.04%)
Price as of Jul 14, 2026 4:18 AM EDT- $2.2BMarket Cap
- -12.33%1-Year Change
- BiotechnologyIndustry
Ocular Therapeut (OCUL)
$9.88+$0.004 (+0.04%)
OCUL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.88 | ||
Change | -$0.32 (-3.14%) | ||
Open | $10.14 | ||
High | $10.19 | ||
Low | $9.76 | ||
Previous Close | $10.20 | ||
Volume | 1,437,618 | ||
30-Day Average Volume | 3,269,222 | ||
1-Week Change | 2.28% | ||
1-Month Change | 10.51% | ||
1-Year Change | -12.33% | ||
3-Year Change | 114.32% | ||
5-Year Change | -23.35% | ||
Fundamentals | |||
Shares Outstanding | 219.0M | ||
Total Assets | $732.5M | ||
Market Cap | $2.2B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $10.8M | ||
Net Income | -$88.6M | ||
Free Cash Flow | -$70.7M | ||
EBIT | -$88.6M | ||
EBITDA | -$87.3M | ||
Net Working Capital | $658.3M | ||
EPS | -$0.40 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | 152 | ||
P/B | 4 | ||
P/E | -26 | ||
PEG | 1 | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue